Physicians Realty Trust - Quarter Report: 2013 June (Form 10-Q)

Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

x      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2013

 

or

 

o         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to

 

Commission file number: 001-36007

 

 

PHYSICIANS REALTY TRUST

(Exact Name of Registrant as Specified in its Charter)

 

 

 

(414) 978-6494

(Registrant’s Telephone Number, Including Area Code)

 

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  o Yes  x No

 

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).  o Yes  o No

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated Filer		o		Accelerated Filer	o
Non-Accelerated Filer		x (Do not check if a smaller reporting company)		Smaller reporting company	o

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  o Yes  x No

 

The number of Registrant’s common shares outstanding on August 23, 2013 was 12,003,597.

 

 

Table of Contents

 

PHYSICIANS REALTY TRUST

 

Quarterly Report on Form 10-Q
for the Quarter Ended June 30, 2013

 

Table of Contents

 

PART I	Financial Information
Item 1.	Financial Statements	1
	Physicians Realty Trust:	1
	Condensed Balance Sheet	1
	Notes to Condensed Balance Sheet	2
	Ziegler Healthcare Real Estate Funds (Predecessor)	4
	Combined Balance Sheets as of June 30, 2013 and December 31, 2012	4
	Combined Statements of Operations for the three and six months ended June 30, 2013 and June 30, 2012	6
	Combined Statements of Owner Equity for the six months ended June 30, 2013 and June 30, 2012	7
	Combined Statements of Cash Flows for the six months ended June 30, 2013 and June 30, 2012	8
	Notes to Combined Financial Statements	9
Item 1A.	Unaudited Pro Forma Consolidated Financial Information	24
	Physicians Realty Trust and Subsidiaries:
	Unaudited Pro Forma Consolidated Balance Sheet as of June 30, 2013	25
	Unaudited Pro Forma Consolidated Statement of Operations for the six months ended June 30, 2013	27
	Notes to Pro Forma Consolidated Financial Statements	28
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	31
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	47
Item 4.	Controls and Procedures	47
PART II.	Other Information
Item 1.	Legal Proceedings	48
Item 1A.	Risk Factors	48
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	48
Item 3.	Defaults Upon Senior Securities	49

 

i

Table of Contents

 

Item 4.	Mine Safety Disclosures	49
Item 5.	Other Information	49
Item 6.	Exhibits	50

 

ii

Table of Contents

 

PART I.  Financial Information

 

Item 1.                                 Financial Statements

 

Physicians Realty Trust

Condensed Balance Sheet

 

		June 30, 2013			December 31, 2012
		(unaudited)
Assets
Assets—Cash		$	1,000		$	—
Liabilities and Shareholder’s Equity
Shareholder’s Equity
Common shares of beneficial interest ($0.01 par value, 1,000 shares authorized, issued and outstanding)		$	10		$	—
Additional paid-in capital		990			$	—
Total Shareholder’s Equity		$	1,000		$	—

 

The accompanying notes are an integral part of these condensed financial statements.

 

Table of Contents

 

Notes to Condensed Balance Sheet

 

Note 1—Organization and Nature of Business

 

Physicians Realty Trust (the “Trust”) was organized in the state of Maryland on April 9, 2013. As of June 30, 2013, the Trust is authorized to issue up to 1,000 shares of common shares of beneficial interest, par value $0.01 per share. The Trust filed a Registration Statement on Form S-11 with the Securities and Exchange Commission with respect to a proposed underwritten initial public offering (the “IPO”) of shares of its common stock.  Immediately prior to the IPO, the trust is authorized to issue up to 50,000,000 common shares of beneficial interest, par value $0.01 per share.

 

The Trust has elected to be taxed as a pass-through entity under subchapter S of the Internal Revenue Code of 1986, but intends to revoke the subchapter S election prior to the closing of a proposed offering of common shares to the public. The Trust intends to elect to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes commencing with a short taxable year beginning on the date of the revocation of the subchapter S election and ending on December 31, 2013. The Trust expects to have little or no taxable income prior to electing REIT status. To qualify as a REIT, the Trust must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of its annual REIT taxable income to its shareholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles).

 

As a REIT, the Trust generally will not be subject to federal income tax to the extent it distributes qualifying dividends to its shareholders. If the Trust fails to qualify as a REIT in any taxable year, it will be subject to federal income tax (including any applicable alternative minimum tax) on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Trust relief under certain statutory provisions. Such an event could materially adversely affect the Trust’s net income and net cash available for distribution to shareholders. However, the Trust intends to organize and operate in such a manner as to qualify for treatment as a REIT. Even if the Trust qualifies for taxation as a REIT, the Trust may be subject to state and local taxes on its income and property and federal income and excise taxes on its undistributed income.

 

The Trust will be a fully integrated, self-administered and self-managed REIT formed primarily to own, operate, acquire and develop healthcare properties. The Trust has had no operations since its formation.

 

Note 2—Formation of the Trust and Offering Transaction

 

Upon completion of the IPO, the Trust will contribute the net proceeds of the IPO to Physicians Realty L.P. (the “Operating Partnership”).  The Trust is the sole general partner of the Operating Partnership. The Operating Partnership is a Delaware limited partnership. The Trust’s and the Operating Partnership’s operations are planned to commence upon completion of the IPO and related formation transactions. Upon completion of the IPO and the related formation transactions, the Trust expects its operations to be carried on through its Operating Partnership and wholly owned subsidiaries of the Operating Partnership. At such time, the Trust, as the general partner of the Operating Partnership, will control the Operating Partnership and consolidate the assets, liabilities and results of operations of the Operating Partnership.

 

2

Table of Contents

 

Note 3—Summary of Significant Accounting Policies

 

Basis of Presentation

 

The balance sheet has been prepared by management in accordance with generally accepted accounting principles.

 

Start Up Costs

 

Start-up costs incurred will be expensed. Costs related to the IPO and related formation transactions have been incurred by our Predecessor. Upon successful completion of the IPO, such costs will be reimbursed to the Predecessor from the proceeds of the IPO.

 

On July 24, 2013, all start-up costs incurred by our Predecessor were reimbursed from the proceeds of the IPO.

 

Note 4—Subsequent Events

 

On July 24, 2013, the Trust completed the IPO by issuing 10,434,782 common shares at a public offering price of $11.50 per share and on August 7, 2013, the Trust issued an additional 1,318,815 common shares at the IPO price of $11.50 per share pursuant to the underwriters’ exercise of their overallotment option to purchase additional common shares pursuant to the underwriting agreement.  Total proceeds to the Trust for the IPO, including the underwriters’ overallotment, were approximately $123.8 million, after deducting underwriting discounts and offering costs.  The Trust contributed the net proceeds to the Operating Partnership in exchange for 81.4% of the common units of partnership interest in the Trust (“OP Units”).

 

In connection with the closing of the IPO, the Trust and the Operating Partnership completed related formation transactions pursuant to which the Operating Partnership acquired from four healthcare real estate funds managed by B.C. Ziegler & Company or Ziegler Healthcare Real Estate Management IV, LLC, each of which is wholly owned by The Ziegler Companies, Inc, the ownership interests in 19 medical office buildings located in ten states in exchange for an aggregate of 2,744,000 OP Units.

 

On August 21, 2013, we, through our Operating Partnership, entered into an Agreement of Sale and Purchase to acquire a post-acute care specialty hospital in Plano, Texas for $18.2 million.

 

On August 29, 2013, the Operating Partnership, as borrower, the Company and certain subsidiaries, entered into a $75.0 million senior secured revolving credit facility. Subject to the satisfaction of certain conditions, including additional lender commitments, the Operating Partnership has the option to increase the borrowing capacity under the revolving credit facility up to $250.0 million. The revolving credit facility has a three-year term with an initial maturity date of August 29, 2016. The Operating Partnership has the option to extend the term to August 29, 2017.  Borrowings under the senior secured revolving credit facility bear interest at rates generally between LIBOR plus 2.65% and LIBOR plus 3.40%.

 

3

Table of Contents

 

Ziegler Healthcare Real Estate Funds (Predecessor)

Combined Balance Sheet
Assets

 

		June 30,			December 31,
		2013			2012
		(unaudited)
Investment Properties
Medical office buildings (Net of accumulated depreciation of $16,524,238 as of June 30, 2013 and $15,118,553 as of December 31, 2012; includes $2,269,121 related to variable interest entity as of June 30, 2013, and $2,296,849 as of December 31, 2012)		$	73,561,063		$	74,758,961
Tenant improvements (Net of accumulated depreciation of $1,518,378 as of June 30, 2013 and $1,376,082 as of December 31, 2012)		3,673,771			3,755,956
Property under development (Related to a variable interest entity)		674,773			674,773
Land (includes $740,000 related to a variable interest entity as of June 30, 2013 and December 31, 2012)		15,463,667			15,463,667
Total Investment Properties		93,373,274			94,653,357
Cash and Cash Equivalents		2,366,052			2,614,036
Receivables—Tenant Receivables (Net of allowance for doubtful accounts of $132,149 as of June 30, 2013 and $104,627 as of December 31, 2012)		556,783			682,402
Deferred Costs (Net of accumulated amortization of $1,331,438 as of June 30, 2013 and $1,380,327 as of December 31, 2012)		995,371			1,107,174
Intangibles (Net of accumulated amortization of $7,269,352 as of June 30, 2013 and $6,907,414 as of December 31, 2012)		4,880,948			5,242,886
Other Assets		4,110,478			3,292,239
Total Assets		$	106,282,906		$	107,592,094

 

The accompanying notes are an integral part of these combined financial statements.

 

4

Table of Contents

 

Ziegler Healthcare Real Estate Funds (Predecessor)

Combined Balance Sheet
Liabilities and Owners’ Equity

 

		June 30,			December 31,
		2013			2012
		(unaudited)
Liabilities
Accounts payable to related parties		$	1,919,399		$	1,530,300
Accounts payable		644,114			801,941
Accrued expenses and other liabilities		1,271,998			1,031,083
Derivative liabilities		453,252			642,940
Notes payable (Includes $2,237,344 related to variable interest entities, as of June 30, 2013 and $2,702,184 as of December 31, 2012)		83,795,086			84,489,017
Total Liabilities		88,083,849			88,495,281
Owners’ Equity
Ziegler Healthcare Real Estate Funds Owners’ Equity
General interest		3,067			3,107
Limited interest		18,250,997			19,064,938
Funds Owners’ Equity		18,254,064			19,068,045
Noncontrolling interest		(55,007		)	28,768
Total Owners’ Equity		18,199,057			19,096,813
Total Liabilities and Owners’ Equity		$	106,282,906		$	107,592,094

 

The accompanying notes are an integral part of these combined financial statements.

 

5

Table of Contents

 

Ziegler Healthcare Real Estate Funds (Predecessor)

Combined Statements of Operations
(Unaudited)

 

		Three Months Ended June 30,						Six Months Ended June 30,
		2013			2012			2013			2012
Revenues
Rental revenues		$	2,534,982		$	2,467,714		$	5,031,549		$	5,037,375
Expense recoveries		786,658			712,396			1,600,925			1,401,286
Other revenues		543			647			5,637			4,741
Total Revenues		3,322,183			3,180,757			6,638,111			6,443,402
Expenses
Management fees		237,700			237,700			475,400			475,400
General and administrative		102,089			29,419			222,021			188,308
Operational expenses		1,260,553			1,184,759			2,524,170			2,350,172
Depreciation and amortization		1,039,480			1,028,795			2,060,492			2,089,369
Loss on sale of property under development		—			—			—			66,853
Total Expenses		2,639,822			2,480,673			5,282,083			5,170,102
Total Operating Income		682,361			700,084			1,356,028			1,273,300
Interest Expense		1,080,743			1,127,128			2,130,143			2,302,768
Change in Fair Value of Derivatives, net		(115,307		)	(31,955		)	(189,688		)	(58,138		)
Combined Net Loss Before Discontinued Operations		(283,075		)	(395,089		)	(584,427		)	(971,330		)
Discontinued Operations
Income from operations on discontinued investment properties		—			33,133			—			63,514
Gain on sale of discontinued investment properties		—			340,173			—			340,173
Total Discontinued Operations		—			373,306			—			403,687
Combined Net Loss		(283,075		)	(21,783		)	(584,427		)	(567,643		)
Less Net Income Attributable to Noncontrolling Interest		21,662			(41,742		)	(125,485		)	(86,041		)
Combined Net Loss Attributable to the Ziegler Funds		$	(261,413	)	$	(63,525	)	$	(709,912	)	$	(653,684	)

 

The accompanying notes are an integral part of these combined financial statements.

 

6

Table of Contents

 

Ziegler Healthcare Real Estate Funds (Predecessor)
Combined Statements of Owner Equity

 

		General Interest			Limited Interest			Total Controlling Interest			Non Controlling Interest			Total Owners Equity
Balance December 31, 2011		$	3,195		$	22,496,639		$	22,499,834		$	112,138		$	22,611,972
Contributions		(7		)	(105,425		)	(105,432		)	105,432			—
Distributions		—			(1,670,750		)	(1,670,750		)	(313,259		)	(1,984,009		)
Net (loss) income		(81		)	(1,655,526		)	(1,655,607		)	124,457			(1,531,150		)
Balance at December 31, 2012		$	3,107		$	19,064,938		$	19,068,045		$	28,768		$	19,096,813
Transfer		—			36,306			36,306			(36,306		)	—
Distributions		—			(140,375		)	(140,375		)	(172,954		)	(313,329		)
Net (loss) income		(40		)	(709,872		)	(709,912		)	125,485			(584,427		)
Balance at June 30, 2013 (unaudited)		$	3,067		$	18,250,997		$	18,254,064		$	(55,007	)	$	18,199,057

 

The accompanying notes are an integral part of these combined financial statements.

 

7

Table of Contents

 

Ziegler Healthcare Real Estate Funds (Predecessor)

Combined Statements of Cash Flows

(Unaudited)

 

		Six Months Ended June 30
		2013			2012
Cash Flows from Operating Activities
Net loss		$	(584,427	)	$	(567,643	)
Adjustments to reconcile net loss to net cash provided by operating activities
Depreciation and amortization		2,060,492			2,300,567
Gain on sale of investment properties		—			(340,173		)
Loss on sale of property under development		—			66,853
Lease Inducement		35,000			35,000
Change in fair value of derivatives, net		(189,688		)	(58,138		)
Provision for bad debts		29,522			121,113
(Increase) decrease in
Tenant receivables		98,171			322,262
Deferred costs		(38,770		)	(96,868		)
Other assets		(738,763		)	(492,137		)
Increase (decrease) in
Accounts payable to related parties		384,394			378,514
Accounts payable		(269,676		)	(187,314		)
Accrued expenses and other liabilities		240,916			160,228
Total Adjustments		1,611,598			2,209,907
Net Cash Provided by Operating Activities		1,027,171			1,642,264
Cash Flows from Investing Activities
Proceeds from sale of investment properties		—			5,547,620
Capital expenditures on investment properties		(267,896		)	(470,901		)
Net Cash (Used in) Provided by Investing Activities		(267,896		)	5,076,719
Cash Flows from Financing Activities
Payments on notes payable		(857,421		)	(5,902,274		)
Proceeds from issuance of debt		163,491			—
Distributions to members and partners		(140,375		)	(637,375		)
Contributions to noncontrolling interest		—			303,783
Distributions to noncontrolling interest		(172,954		)	(416,499		)
Net Cash Used in Financing Activities		(1,007,259		)	(6,652,365		)
Net (Decrease) Increase in Cash and Cash Equivalents		(247,984		)	66,618
Cash and Cash Equivalents, Beginning of Year		2,614,036			1,931,885
Cash and Cash Equivalents, End of Period		$	2,366,052		$	1,998,503
Supplemental Disclosure of Cash Flow Information Interest paid during the year		$	2,130,894		$	2,295,273

 

The accompanying notes are an integral part of these combined financial statements.

 

8

Table of Contents

 

Ziegler Healthcare Real Estate Funds

Notes to Condensed Combined Financial Statements

 

Note 1—Organization and Nature of the Business

 

Ziegler Healthcare Real Estate Funds, collectively the “Ziegler Funds”, consist of Ziegler Healthcare Real Estate Fund I, LLC (“Fund I”), Ziegler Healthcare Real Estate Fund II, LLC (“Fund II”), Ziegler Healthcare Real Estate Fund III, LLC (“Fund III”), and Ziegler Healthcare Real Estate Fund IV, LP (“Fund IV”). The Funds, through subsidiaries, are principally engaged in making investments in healthcare real estate or companies that own healthcare real estate. Fund I, Fund II, and Fund III are limited liability companies organized under the laws of the State of Delaware. For each of these funds, The Ziegler Companies, Inc. (“ZCO”) has contributed $1,000 as the general member. Fund IV is a limited partnership organized under the laws of the state of Delaware. A wholly owned subsidiary of ZCO has contributed $1,000 as the general partner. B.C. Ziegler and Company (“BCZ”), a wholly owned subsidiary of ZCO, is the manager of Fund I, Fund II and Fund III and Ziegler Healthcare Real Estate Management IV, LLC, or ZHREM IV, a wholly owned subsidiary of ZCO is the manager of Fund IV.

 

The Ziegler Funds had private capital commitments as described below, all of which have been fully contributed:

 

Fund		Total Commitments
I		$	15,100,000
II		17,800,000
III		9,050,000
IV		5,616,000
Total		$	47,566,000

 

Note 2—Summary of Significant Accounting Policies

 

The accompanying unaudited condensed combined financial statements reflect all adjustments which are, in the opinion of management, necessary for a fair presentation of the results for the three and six month periods ended June 30, 2013 and 2012 pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited financial statements included in the Company’s final prospectus dated July 18, 2013 filed with the Securities and Exchange Commission on July 19, 2013. Operating results for interim periods are not necessarily indicative of results that may be expected for the entire year ending December 31, 2013.

 

Aspects of the Limited Liability Companies and Limited Partnership

 

Each of the Ziegler Funds is organized as either a limited liability company or a limited partnership. Each member’s/partner’s liability is limited to the capital contributed. Allocations of income and loss are made to the capital accounts as described in the following paragraph. Distributions of cash from operations will be made periodically. The distributions will be made to members/partners in accordance with their ownership percentages.

 

9

Table of Contents

 

Allocations of income and loss are made to the capital accounts of members/partners in proportion to the committed capital. The distributions will be made in the following order: (1) to members/partners on a preferred 8 percent annual return based on their unreturned capital contributions for Fund I, Fund II and Fund III and 7 percent for Fund IV, (2) to repay members/partners unreturned capital contributions, and (3) 80 percent to members/partners based upon their percentage interests and 20 percent to ZCO.

 

The Ziegler Funds were initially capitalized as follows:

 

		General Interest		Limited Interest
Fund		Investment Units				Unit Price
I		0.01		151		$	100,000
II		0.02		356		$	50,000
III		0.01		90.5		$	100,000
IV		0.02		112.3		$	50,000

 

Principles of Combination

 

As described in Note 1, the combined financial statements contain the financial position and results of operations of the Ziegler Funds, which are managed by BCZ and ZHREM IV, and are engaged in similar business activities. It is intended that the Ziegler Funds will contribute their interests in their properties to Physicians Realty L.P., which will be funded primarily through an initial public offering of its common shares.

 

Principles of Consolidation

 

The Ziegler Funds include the following consolidated subsidiaries as of June 30, 2013 and December 31, 2012:

 

		Fund Ownership %
Entity		I		II		III		IV
Ziegler Michigan 5, LLC (Michigan 5)		100	%
Ziegler Georgia 6, LLC (Georgia 6)		100	%
Ziegler Michigan 6, LLC (Michigan 6)		100	%
Ziegler Georgia 7, LLC (Georgia 7)		50	%
Ziegler Florida 4, LLC (Florida 4)		100	%
Ziegler Georgia 21, LLC (Georgia 21)		79.4	%			20.6	%
Ziegler Texas 8, LLC (Texas 8)		100	%
Ziegler Arizona 23, LLC (Arizona 23)		50	%
Ziegler Illinois 12, LLC (Illinois 12)				100	%
Ziegler Michigan 12, LLC (Michigan 12)				100	%
Ziegler Tennessee 14, LLC (Tennessee 14)				100	%
Ziegler Ohio 9, LLC (Ohio 9)				83.21	%			16.79	%
Ziegler Maine 15, LLC (Maine 15)				56.77	%	43.23	%
Ziegler Wisconsin 16, LLC (Wisconsin 16)						100	%
Ziegler Georgia 17, LLC (Georgia 17)						100	%
Ziegler Illinois 18, LLC (Illinois 18)						100	%
Ziegler Ohio 19, LLC (Ohio 19)						100	%
Ziegler Georgia 20, LLC (Georgia 20)						100	%
Ziegler Wisconsin 24, LLC (Wisconsin 24)								100	%

 

The Ziegler Funds consolidate the following less than 100 percent owned subsidiaries, or investees of those subsidiaries, due to majority voting control:

 

10

Table of Contents

 

Sandwich Development Partners LLC (Sandwich)—In 2006, Illinois 12 and another investor (Investing Member) entered into an agreement with IDP Sandwich Development Partners (IDP) to form Sandwich. Illinois 12, the Investing Member and IDP have contributed $1,100,000, $100,000 and $100, respectively. The agreement provides that Illinois 12 and the Investing Member will receive a 7 percent preferred return on their investment. The agreement further requires payment of the preferred return and return of invested capital of Illinois 12 and the Investing Member be returned prior to any allocation of profits to IDP. After Illinois 12 and the Investing Member receive the preferred return and return of invested capital, profits will be split 59.6 percent to Illinois 12, 5.4 percent and 35 percent to IDP.

 

Maine 15, LLC—In 2007, Fund II and Fund III formed Maine 15 for the purpose of investing in Bath Road Associates, LLC (Bath Road), which owns a medical office building. Maine 15 and other investors entered into an agreement with Bath Road Management, LLC (BRM) to form Bath Road. The agreement provides that Maine 15 will receive 66.33 percent of cash flows from the property, as defined, with the remaining cash flows divided between BRM and other investors, 25.51 percent and 8.16 percent, respectively.

 

Illinois 18, LLC—In 2007, Illinois 18 entered into an agreement with IDP Remington Holdings (IDP) to form Remington Development Partners, LLC (Remington). Illinois 18 has contributed $1,300,000. The agreement provides that Illinois 18 will receive a 7 percent preferred return on its investment. The agreement further provides that the preferred return and capital investment by Illinois 18 be returned prior to any allocation of profits to IDP. After Illinois 18 receives a 7 percent preferred return and return of capital, profits will be split 65 percent to Illinois 18 and 35 percent to IDP. The noncontrolling interest on Fund III’s assets and liabilities consists of Illinois 18 and IDP.

 

Georgia 7, LLC—In 2012, Georgia 7 entered into a 5 year lease with a tenant in exchange for a 50 percent ownership interest in Georgia 7. Prior to this arrangement, Georgia 7 was wholly owned by Fund I. As part of the agreement, Fund I retained a 51 percent voting interest in Georgia 7. As a result, Georgia 7’s accounts have been consolidated with Fund I’s consolidated financial statements.

 

The Ziegler Funds consolidate all variable interest entities in which it holds a variable interest and is deemed to be the primary beneficiary of the variable interest entity. Generally, a variable interest entity, or VIE, is an entity with at least one of the following conditions: (1) the total equity investment at risk is insufficient to allow the entity to finance its activities without additional subordinated financial support; or (2) the holders of the equity investment at risk, as a group, lack any one of the following three characteristics: (i) the power to direct the entity’s activities that most significantly impact its economic performance, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity. The primary beneficiary of a VIE is an entity that has a variable interest or a combination of variable interests that provide that entity with a controlling financial interest in the VIE. An entity is deemed to have a controlling financial interest in a VIE if it has both of the following characteristics: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, and (2) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

 

The combined Ziegler Funds consolidate the following VIE’s for which it is the primary beneficiary:

 

In 2005, Ziegler Florida 4, LLC (Florida 4) entered into an agreement with CED SS II, LLC (CED) to form Ziegler CED Summerfield Square, LLC (Summerfield). Summerfield is in the business of property development. Florida 4 contributed $629,000 of cash in exchange for a 40 percent interest in Summerfield. CED agreed to manage the development efforts of Summerfield and assume certain risks of project overruns in exchange for a 60 percent interest in Summerfield. The agreement provides that

 

11

Table of Contents

 

Florida 4 will receive a 10 percent preferred return on its capital investment in Summerfield of $629,000. The agreement requires payment of Florida 4’s preferred return and return of invested capital before any allocation of profits to CED. After Florida 4 receives its 10 percent preferred return and its capital investment is returned, Summerfield’s profits will be split 60 percent to CED and 40 percent to Florida 4. CED will also receive a 4.25 percent development fee on the ultimate sale of the medical office buildings.

 

The Ziegler Funds have determined that, Florida 4 is the primary beneficiary of Summerfield because Florida 4 has the power to direct activities of Summerfield that most significantly impact Summerfield’s economic performance. Those activities include management oversight and negotiation of unit sales related to the property. Should additional financing be needed for Summerfield in the future, it is expected that Florida 4 will provide that additional support due to ownership.

 

The following presents selected information for Summerfield as of and for the three and six months ended June 30, 2013 and as of and for the year ended December 31, 2012:

 

		Three Months Ended:			Six Months Ended:
		June 30, 2013			June 30, 2013			December 31, 2012
		(unaudited)			(unaudited)
Property under Development		$	—		$	674,773		$	674,773
Other assets		—			4,276			5,227
Total Assets		$	—		$	679,049		$	680,000
Long-Term Debt		$	—		$	455,001		$	421,675
Other liabilities		—			153,932			167,690
Total Liabilities		$	—		$	608,933		$	589,365
Real estate sale		$	—		$	—		$	685,000
Operating loss		(9,003		)	(20,518		)	(340,250		)
Net loss		(9,003		)	(20,518		)	(340,250		)

 

On August 1, 2011, Arizona 23 issued a 50% equity interest in the entity to an unrelated third party and current lessee, in exchange for the lessee executing a new 10 year lease. To estimate the value of the equity interest issued, management determined the gross value of the property to be approximately $3,900,000 using a 7.75% capitalization rate and a stabilized annual net operating income of $302,000. This gross value was reduced by the property’s outstanding mortgage debt of approximately $2,500,000, to yield a net equity value of approximately $1,400,000. Therefore, a 50% net equity interest in Arizona 23 approximated $700,000 on the transaction date. The net present value of the tenant lease on the date of the transaction was estimated to be approximately $1,400,000 based on future monthly gross lease payments for the ten-year term of the lease of approximately $2,200,000 using a 7.75% discount rate. Therefore, 50% of the net present value of the lease approximated $700,000 on the date of the transaction, equivalent to a 50% net equity interest in the property, and thus, no gain or loss was recorded on the transaction. Prior to this arrangement, Arizona 23 was wholly owned by Fund I. Arizona 23’s accounts have been consolidated with Fund I’s consolidated financial statements.

 

12

Table of Contents

 

Management determined that the lessee received a lease inducement in the amount of $700,000 from Arizona 23. Accounting standards require that the lease inducement be amortized on a straight line basis over the 10 year lease term. On August 1, 2011, the Ziegler Funds’ management recorded the lease inducement as an increase to other assets and owners’ equity of $700,000. For each of the three and six months ended June 30, 2013 and 2012, the amortization of the lease inducement resulted in a decrease in rental revenues of $17,500 and $35,000, respectively.

 

Following the guidance in generally accepted accounting principles, Fund I is the primary beneficiary of Arizona 23 because Fund I has the power to direct activities of Arizona 23 that most significantly impact its economic performance. Those activities include serving as the managing member with oversight over the property including the ability to approve the sale of the property. Should additional financing be needed for Arizona 23 in the future, it is expected that Fund I will provide that additional support.

 

The following presents selected information for Arizona 23 as of and for the three and six months ended June 30, 2013 and as of and for the year ended December 31, 2012:

 

		Three Months Ended:			Six Months Ended:
		June 30,			June 30,			December 31,
		2013			2013			2012
		(unaudited)			(unaudited)
Investment property		$	—		$	3,009,121		$	3,036,850
Other assets		—			825,643			878,913
Total assets		$	—		$	3,834,764		$	3,915,763
Long-term debt		$	—		$	2,237,344		$	2,280,508
Other liabilities		—			71,417			68,614
Total liabilities		$	—		$	2,308,761		$	2,349,122
Rental revenue		$	83,014		$	166,287		$	327,635
Operating income		53,930			124,757			330,483
Net (loss) income		(7,586		)	(12,639		)	(88,193		)

 

All significant intercompany accounts and transactions have been eliminated in consolidation and combination. The effects of eliminations of revenues and expenses due to intercompany transactions between majority-owned subsidiaries and consolidated VIEs are not attributed to noncontrolling interest in the VIEs.

 

Subsequent to June 30, 2013:

 

On July 24, 2013, in connection with the completion of the IPO and formation transactions, Physicians Realty L.P. purchased the 50% joint venture equity interest in Arizona 23 (Arrowhead Commons) not owned by the Ziegler Funds for $850,000, resulting in 100% ownership of this property by Physicians Realty L.P.

 

Classification of Assets and Liabilities

 

The financial affairs of the Ziegler Funds generally do not involve a business cycle since the realization of assets and the liquidation of liabilities are usually dependent on the Ziegler Funds’ circumstances. Accordingly, the classification of current assets and current liabilities is not considered appropriate and has been omitted from the combined statements of assets and liabilities.

 

13

Table of Contents

 

Impairment of Intangible and Long-Lived Assets

 

The Ziegler Funds’ evaluate the recoverability of the recorded amount of intangible and long-lived assets whenever events or changes in circumstances indicate that the recorded amount of an asset may not be fully recoverable. Impairment is assessed when the undiscounted expected future cash flows derived from an asset are less than its carrying amount. If Ziegler Funds determine that an asset is impaired, the impairment to be recognized is measured as the amount by which the recorded amount of the asset exceeds its fair value. Assets to be disposed of are reported at the lower of the recorded amount or fair value less cost to sell. Fair value is determined using a discounted future cash flow analysis.

 

The Ziegler Funds did not recognize any impairments for the three or six months ended June 30, 2013 and 2012.

 

Escrow Reserves

 

The Ziegler Funds are required to maintain various escrow reserves on their notes payable to cover future property taxes and insurance, and tenant improvement costs as defined in each loan agreement. The total reserves as of June 30, 2013 and December 31, 2012 are $1,264,572 and $1,060,003, respectively, which are included in other assets on the combined balance sheets.

 

Rental Revenue

 

Rental revenue, less lease inducement, is recognized on a straight-line basis over the terms of the related leases when collectability is reasonably assured. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue for amounts more or less than amounts currently due from tenants. Amounts recognized in excess of amounts currently due from tenants are included in other assets and were $1,289,702 and $1,290,038 as of June 30, 2013 and December 31, 2012, respectively. If the Ziegler Funds determine that collectability of straight-line rents is not reasonably assured, the Ziegler Funds limit future recognition to amounts contractually owed and, where appropriate, establish an allowance for estimated losses.

 

Tenant recoveries related to reimbursement of real estate taxes, insurance and other operating expenses are recognized as rental revenue in the period the applicable expenses are incurred. The reimbursements are recorded at gross, as the Ziegler Funds are generally the primary obligor with respect to real estate taxes and purchasing goods and services from third-party suppliers, have discretion in selecting the supplier and bear the credit risk. Property taxes paid by tenants in accordance with the terms of triple net leases, and the corresponding expense, have been included in rental revenue and operational expenses, respectively, in the combined statements of operations of the Ziegler Funds.

 

Management Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the combined financial statements and the reported amounts of revenue and expenses reported in the period. Significant estimates are made for the valuation of real estate and intangibles, valuation of financial instruments, impairment assessments and fair value assessments with respect to purchase price allocations. Actual results could differ from these estimates.

 

14

Table of Contents

 

Note 3—Intangibles

 

Amortization expense related to intangibles was $371,203 for each of the six month periods ended June 30, 2013 and 2012. Amortization expense related to intangibles was $183,967 and $173,312 for the three months ended June 30, 2013 and 2012, respectively. Future amortization of the intangible assets as of June 30, 2013, is as follows:

 

Year Ending December 31:
2013		$	371,203
2014		695,068
2015		661,255
2016		648,520
2017		472,357
Thereafter		2,032,545
Total		$	4,880,948

 

Note 4—Notes Payable

 

		June 30,			December 31,
		2013			2012
Michigan 6, mortgage loan due in July 2013; monthly payments of principal and interest of $26,535, with a final balloon payment of $2,449,329 due at the maturity date; interest rate of LIBOR plus 1.6% per annum, effective rate of 1.79% as of June 30, 2013.(4)		$	2,329,673		$	2,466,919
Georgia 7, mortgage loan due in June 2017; interest-only payments through June 2009, effective July 2009, monthly principal and interest payments of $39,890, with a final balloon payment of $5,869,275 due at the maturity date; interest rate of 5.942% per annum.		6,356,418			6,403,977
Arizona 23, mortgage loan due in October 2013; monthly payments principal and interest of $15,000 through October 2012; effective November 2012, monthly payments of principal and interest of $7,194, with a final balloon payment of $2,208,568 due at the maturity date; interest rate of LIBOR plus 3.25% per annum, effective rate of 3.44% as of June 30, 2013.(4)		2,237,344			2,280,508
Texas 8, mortgage loan due in October 2013; monthly payments of principal and interest of $8,171, with a final balloon payment of $2,012,853 due at the maturity date; interest rate of LIBOR plus 4% per annum, effective rate of 4.19% as of June 30, 2013.(4)		2,135,535			2,184,559
Georgia 6, mortgage loan due in October 2013; monthly payments of principal and interest of $4,224, with a final balloon payment of $1,090,963 due at the maturity date; interest rate of LIBOR plus 4% per annum, effective rate of 4.19% as of June 30, 2013.(4)		1,107,858			1,133,200
Michigan 5, mortgage loan due in October 2013; monthly payments of principal and interest of $5,106, with a final balloon payment of $835,927 due at the maturity date; interest rate of LIBOR plus 4% per annum, effective rate of 4.19% as of June 30, 2013.(4)		854,191			884,825
Georgia 21, mortgage loan due in July 2013; monthly payments and interest of $28,140 until June 2012, effective July 2012 monthly payment of principal and interest of $29,980, with a final balloon payment of $17,226,037 due at the maturity date; interest rate of LIBOR plus 3.05% per annum, effective rate of 3.24% as of June 30, 2013.(4)		17,224,530			17,404,410

 

15

Table of Contents

 

		June 30,			December 31,
		2013			2012
Mezzanine loans payable to three private investors; monthly payments of interest only at an annual rate of 12%; due in July 2013. (4)		4,400,000			4,400,000
Summerfield, mortgage loan due in March 2012; monthly payments of interest only until March 2011; effective April 2011, monthly payments of principal and interest of $5,177; interest rate of 4.25% per annum.(1) (4)		359,031			325,706
Summerfield, $250,000 revolving line of credit due in March 2012; monthly payments of interest only until March 2011; effective April 2011, monthly payments of principal and interest of $8,000; interest rate of 4.25% per annum.(1)(4)		95,970			95,970
Tennessee 14, mortgage loan due June 2017; monthly payments of principal and interest of $66,081, with a final balloon payment of $9,820,300 due at the maturity date; interest rate of 5.81% per annum.		10,666,060			10,747,849
Michigan 12, mortgage loan due January 2017; monthly payments of principal and interest of $36,299, with a final balloon payment of $5,035,493 due at the maturity date; interest rate of 5.93% per annum. (4)		5,563,609			5,613,726
Maine 15, mortgage loan due June 2016; monthly payments of principal and interests of $33,160, with a final balloon payment of $7,639,025 due at the maturity date; interest rate of LIBOR plus 2.25%, effective rate of 2.44% as of June 30, 2013.		8,170,704			8,265,443
Illinois 12, mortgage loan due January 2018; monthly payments of principal and interest of $41,428, with a final balloon payment of $6,169,464 due at maturity; interest rate of 5.35% per annum.		6,815,452			6,847,333
Wisconsin 16, mortgage loan due September 2032 with an anticipated repayment date of September 2017, monthly payments of principal and interest of $20,741; interest rate of 6.58% per annum. If not repaid by anticipated repayment date, effective September 2017, monthly payments adjust based on the property’s cash flow (as defined in the agreement) with the interest rate becoming the greater of 8.58% or the 10 year U.S. treasury rate plus 3%.		2,856,851			2,885,864
Georgia 17, mortgage loan due October 2013, monthly payments of principal and interest of $9,250, with final balloon payment of $2,349,500 due at maturity date; interest rate of LIBOR plus 3.25%, effective rate of 3.44% as of June 30, 2013.(4)		2,377,250			2,432,750
Ohio 19, mortgage loan due February 2018, effective April 2011, monthly payments of principal and interest t $13,242; interest rate of 5.84% per annum. Effective March 2013 and every six months thereafter, the interest rate is subject to adjustment to LIBOR plus 2.4%, but will not exceed 11.31%.(4)		2,152,925			2,174,646
Georgia 20, mortgage loan due July 2013, monthly payments of principal and interest of $10,755, with final balloon payment of $1,617,519 due at maturity date; interest rate of 6.25% per annum.		1,618,812			1,631,947
Remington, mortgage loan due September 2017, monthly payments of principal and interest of $36,675, with a final balloon payment of $5,235,023 due at maturity date; interest rate of LIBOR plus 2.75%, effective rate of 2.94% as of June 30, 2013.(2)		6,472,873			6,309,385
Wisconsin 24, revolving bank line of credit due in August 2014; monthly payments of interest only; interest rate of LIBOR plus 3.25% per annum, effective rate of 3.44% as of June 30, 2013.(3)(4)		—			—
		$	83,795,086		$	84,489,017

 

16

Table of Contents

 

(1)                  On January 24, 2013, Summerfield entered into a forbearance agreement with the lender regarding its mortgage note and outstanding line of credit, pursuant to which the lender agreed not to exercise its rights and remedies available under the forbearance agreement. The forbearance period extends through September 30, 2013, at which time the mortgage note and line of credit is due.

(2)                  The note was refinanced on September 18, 2012 with an effective date of September 28, 2012. Prior to the refinancing, the loan was payable in monthly payments of principal and interest of $23,468, at an interest rate of LIBOR plus 1.6%.

(3)                  The revolving line of credit is secured by the investment property owned by Wisconsin 24. Fund IV is contingently liable under certain circumstances for up to 100 percent of the borrowings under the revolving line of credit. As of June 30, 2013, the maximum available borrowings under this agreement were $1,180,000.

(4)                  On July 24, 2013, proceeds from the IPO were used to repay outstanding indebtedness on the following ten properties:

 

Property		Amount Repaid
Arizona 23 (Arrowhead Commons)		$	2,237,344
Georgia 20 (Austell Medical Office Building)		1,618,812
Georgia 17 (Decatur Medical Office Building)		2,377,250
Texas 8 (El Paso Medical Office Building)		2,135,535
Michigan 5 (Farmington Professional Pavilion)		854,191
Michigan 6 (Ingham Medical Center)		2,329,673
Ohio 19 (New Albany Professional Building)		2,152,925
Georgia 6 (Northpark Trail)		1,107,858
Summerfield Square		455,001
Georgia 21 (Summit Healthplex — Senior Debt)		17,224,530
Georgia 21 (Summit Healthplex — Mezzanine Debt)		4,400,000
		$	36,893,119

 

17

Table of Contents

 

Scheduled principal payments due on notes payable as of June 30, 2013, are as follows:

 

Year Ending December 31:
2013		$	35,251,314
2014		1,054,578
2015		1,098,285
2016		8,624,861
2017		29,604,187
Thereafter		8,161,861
Total Payments		$	83,795,086

 

Mortgage loans are secured by the respective investment property owned by the borrower. The mortgage loans associated with Michigan 5, Michigan 6, Georgia 6, Georgia 7, Georgia 21, Arizona 23, and Texas 8 are partially guaranteed by Fund I. Fund I is contingently liable under certain circumstances for up to 100 percent of the outstanding mortgage loans.

 

Michigan 6 is currently in default with respect to the minimum debt service coverage ratio and minimum global debt service coverage ratio covenants as it relates to the mortgage loan on its property and has not obtained a waiver from the bank. Michigan 6 continues to remit all scheduled mortgage payments on a timely basis and management does not anticipate any adverse impact to the combined financial statements as a result of the noncompliance as no action has been taken by the lender to demand payment or exercise any other remedies or rights as stipulated in the loan agreement. Under the loan agreement for the Georgia 21 mortgage loan, Fund I is currently in default with respect to the minimum level of tangible net worth covenant and has not obtained a waiver from the lender. Georgia 21 continues to remit all scheduled mortgage payments on a timely basis and management does not anticipate any adverse impact to the combined financial statements as a result of the noncompliance as no action has been taken by the lender to demand payment or exercise any other remedies or rights as stipulated in the loan agreement. Georgia 21 is currently in compliance with its minimum debt service ratio covenant as of June 30, 2013.

 

Subsequent to June 30, 2013:

 

On July 24, 2013, in connection with the completion of the IPO and formation transactions, Physicians Realty L.P. repaid approximately $36.9 million of outstanding indebtedness on ten properties.

 

On August 29, 2013, the Operating Partnership, as borrower, the Company and certain subsidiaries, entered into a $75.0 million senior secured revolving credit facility. Subject to the satisfaction of certain conditions, including additional lender commitments, the Operating Partnership has the option to increase the borrowing capacity under the revolving credit facility up to $250.0 million. The revolving credit facility has a three-year term with an initial maturity date of August 29, 2016. The Operating Partnership has the option to extend the term to August 29, 2017.  Borrowings under the senior secured revolving credit facility bear interest at rates generally between LIBOR plus 2.65% and LIBOR plus 3.40%

 

Note 5—Fair Value Measurements

 

Accounting standards require certain assets and liabilities be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value.

 

In general, fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Funds have the ability to access. Fair values determined by Level 2 inputs use

 

18

Table of Contents

 

other inputs that are observable, either directly or indirectly. These Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Significant Level 2 inputs include interest rate swaps.

 

Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset. These level 3 fair value measurements are based primarily on management’s own estimates using pricing models, discounted cash flow methodologies, or similar techniques taking into account the characteristics of the asset.In instances where inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Funds assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each asset or liability.

 

The Ziegler Funds measure their interest rate swaps at fair value on a recurring basis. The fair value of ($453,252) and $(642,940) as of June 30, 2013 and December 31, 2012, respectively, is based on primarily level 2 inputs described above.

 

The Ziegler Funds’ derivative instruments (Note 6) are not traded on an exchange. The Ziegler Funds obtained the fair value of the swaps from the counterparty. They then tested that fair value against a fair value determined by a methodology that included using the income approach to value the derivatives, using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present amount (discounted) assuming that participants are motivated, but not compelled to transact. Level 2 inputs for the swap valuations were limited to quoted prices for similar assets or liabilities in active markets (specifically future contracts) and inputs other than quoted prices that were observable for the asset or liability (specifically LIBOR cash and swap rates, implied volatility for options, caps and floors, basis swap adjustments and credit risk at commonly quoted intervals). Mid-market pricing was used as a practical expedient for fair value measurements. Key inputs, including the cash rates for very short-term, futures rates and swap rates beyond the derivative maturities were bootstrapped to provide spot rates at resets specified by the swaps (reset rates were then further adjusted by the basis swaps, if necessary). Inputs were collected from Bloomberg as the last price on the last market day of the period. The same rates used to bootstrap the yield curves were used to discount the future cash flows prior to the credit risk effect for both the Ziegler Funds and the credit risk of its counterparty when determining the fair value of derivatives under generally accepted accounting principles. The fair values resulting from the separate calculations were not significantly different.

 

Both direct and indirect observable inputs may be used to determine the fair value of the positions classified as Level 2 assets and liabilities. As a result, the unrealized gains and losses for these asset and liabilities presented above may include changes in fair value that were attributable to both direct and indirect observable inputs. Changes in fair value of the interest rate swaps totaled $(115,307) and $(39,763) and $(189,688) and $(58,138) for the three and six months ended June 30, 2013 and 2012, respectively, and are included in the combined statement of operations. The fair value was obtained from the swaps’ counterparty. The following table sets forth by level within the fair value hierarchy the Ziegler Fund’s assets and liabilities that were accounted for on a nonrecurring basis as of December 31, 2012.

 

19

Table of Contents

 

					Nonrecurring Fair Value Measurements At Report Date using:
		Fair Value as of December 31, 2012			Quoted Prices in Active Markets for Identical Assets (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)			Total Gains (Losses) for the Year Ended December 31, 2012
Medical office buildings		$	3,588,594		$	—		$	—		$	3,588,594		$	(614,540	)
Land		1,210,406			—			—			1,210,406			(231,594		)
Property under development		674,773			—			—			674,773			(90,455		)
		$	5,473,773		$	—		$	—		$	5,473,773		$	(936,589	)

 

The impairment of the medical office buildings reference above mainly resulted from declines in current and projected operating results and cash flows of the properties. (See Note 2)  There were no fair value measurements on a nonrecurring basis as of June 30, 2013.

 

The following table summarizes the quantitative inputs and assumptions used for items categorized in Level 3 for the fair value hierarchy as of December 31, 2012. There were no changes in the quantitative inputs and assumptions used for items categorized in Level 3 for the fair hierarchy as of June 30, 2013. The disclosure below excludes information on unobservable inputs that are non-quantitative such as unadjusted prices from recent transactions or third party valuations.

 

Asset Category		Fair value at December 31, 2012			Valuation Techniques		Unobservable Inputs		Ranges
Investment in real estate properties		$	4,799,000		Discounted cash flow		Discount rate		10.7-13.5%
							Capitalization rate		7.7-10.5%
							Vacancy rate		9.41-17.8%
Property under development		$	674,773		Market comparable/ Discounted cash flow		Capitalization rate		9-10%

 

The carrying amounts of cash and cash equivalents, tenant receivables, payables, and accrued interest are reasonable estimates of fair value because of the short maturities of these instruments. Fair values for notes payable are estimates based on rates currently prevailing for similar instruments of similar maturities.

 

The following table presents the fair value of other financial instruments. The swaps are measured at fair value on a recurring basis.

 

		June 30,						December 31,
		2013						2012
		(unaudited)
		Carrying Amount			Fair Value			Carrying Amount			Fair Value
Notes payable(1)		$	83,795,086		$	84,655,255		$	84,489,017		$	86,982,366
Interest rate swaps—Liabilities		$	453,252		$	453,252		$	642,940		$	642,940

 

(1)                  For disclosure purposes only.

 

20